[1]
Karthick, M., Akkena, R. and Loganathan, K. 2026. The evolution of active targeting in cancer therapy: bridging molecular biomarkers and intelligent nanomedicine. BOHR Journal of Pharmaceutical Studies. 4, 1 (Jun. 2026), 29–38. DOI:https://doi.org/10.54646/BJOPS.2026.21.